Evaluating the cytotoxicity of innate immune effector cells using the GrB ELISPOT assay

BACKGROUND: This study assessed the Granzyme B (GrB) ELISPOT as a viable alternative to the (51)Cr-release assay for measuring cytotoxic activity of innate immune effector cells. We strategically selected the GrB ELISPOT assay because GrB is a hallmark effector molecule of cell-mediated destruction...

Descripció completa

Dades bibliogràfiques

Publicat a:	J Transl Med
Autors principals:	Shafer-Weaver, Kimberly A, Sayers, Thomas, Kuhns, Douglas B, Strobl, Susan L, Burkett, Mark W, Baseler, Michael, Malyguine, Anatoli
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2004
Matèries:	Methodology
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC522821/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15380049/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1479-5876-2-31
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!